Literature DB >> 33716953

TOX3 Promotes Ovarian Estrogen Synthesis: An RNA-Sequencing and Network Study.

Yuanyuan Man1,2,3,4,5, Rusong Zhao1,2,3,4,5, Xueying Gao1,2,3,4,5, Yue Liu1,2,3,4,5, Shigang Zhao1,2,3,4,5, Gang Lu6, Wai-Yee Chan6, Peter C K Leung7, Yuehong Bian1,2,3,4,5.   

Abstract

Background: Women who undergo chronic exposure to excessive estrogen are at a high risk of developing breast cancer. TOX3 has been reported to be highly expressed in breast tumors and is closely related to estrogen receptors. However, the effect of TOX3 on estrogen synthesis remains poorly understood.
Methods: Using lentiviruses as a vector, we stably overexpressed TOX3 in the ovarian granulosa cell line KGN, the cells where estradiol is primarily produced, to investigate its role in estrogen production as well as cell viability and apoptosis. RNA-Sequencing was applied to uncover the global gene expression upon TOX3 overexpression.
Results: We observed an increased level of cell viability and a reduced cell apoptosis rate after TOX3 overexpression, and the level of estradiol in the cell culture supernatant also increased significantly. Gene set enrichment analysis of the transcriptome showed that the ovarian steroidogenesis pathway was significantly enriched. Similarly, pathway mapping using the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses also showed that TOX3 overexpression affects the ovarian steroidogenesis pathway. Further experiments showed that upregulated FSHRCYP19A1, and BMP6 accounted for the enhanced estrogen synthesis.
Conclusion: Our study demonstrated that TOX3 quantitatively and qualitatively stimulates estrogen synthesis by enhancing estrogen signaling pathway-related gene expression in ovarian granulosa cells. These findings suggest that TOX3 may play a vital role in the pathogenesis of breast cancer.
Copyright © 2021 Man, Zhao, Gao, Liu, Zhao, Lu, Chan, Leung and Bian.

Entities:  

Keywords:  GSEA; KGN; RNA-Seq; TOX3/TNRC9; breast cancer; estrogen

Mesh:

Substances:

Year:  2021        PMID: 33716953      PMCID: PMC7945945          DOI: 10.3389/fendo.2020.615846

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  42 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

3.  Expression of follicle-stimulating hormone receptor in tumor blood vessels.

Authors:  Aurelian Radu; Christophe Pichon; Philippe Camparo; Martine Antoine; Yves Allory; Anne Couvelard; Gaëlle Fromont; Mai Thu Vu Hai; Nicolae Ghinea
Journal:  N Engl J Med       Date:  2010-10-21       Impact factor: 91.245

Review 4.  Vascular Endothelial FSH Receptor, a Target of Interest for Cancer Therapy.

Authors:  Nicolae Ghinea
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

Review 5.  Breast cancer.

Authors:  Nadia Harbeck; Frédérique Penault-Llorca; Javier Cortes; Michael Gnant; Nehmat Houssami; Philip Poortmans; Kathryn Ruddy; Janice Tsang; Fatima Cardoso
Journal:  Nat Rev Dis Primers       Date:  2019-09-23       Impact factor: 52.329

Review 6.  Derailed estrogen signaling and breast cancer: an authentic couple.

Authors:  Bramanandam Manavathi; Oindrilla Dey; Vijay Narsihma Reddy Gajulapalli; Raghavendra Singh Bhatia; Suresh Bugide; Rakesh Kumar
Journal:  Endocr Rev       Date:  2012-09-04       Impact factor: 19.871

7.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

Review 8.  Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.

Authors:  Hsun-Ming Chang; Jie Qiao; Peter C K Leung
Journal:  Hum Reprod Update       Date:  2016-10-26       Impact factor: 15.610

9.  The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle.

Authors:  Gregory F Erickson; Shunichi Shimasaki
Journal:  Reprod Biol Endocrinol       Date:  2003-02-05       Impact factor: 5.211

Review 10.  Oestrogen exposure and breast cancer risk.

Authors:  Ruth C Travis; Timothy J Key
Journal:  Breast Cancer Res       Date:  2003-07-28       Impact factor: 6.466

View more
  3 in total

Review 1.  Synthesis, Regulatory Factors, and Signaling Pathways of Estrogen in the Ovary.

Authors:  Chuyu Xiao; Jing Wang; Chunping Zhang
Journal:  Reprod Sci       Date:  2022-04-06       Impact factor: 3.060

2.  Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.

Authors:  Yajing Xu; Didi Chen; Lanxiao Shen; Xiaowei Huang; Yi Chen; Huafang Su
Journal:  Front Genet       Date:  2021-12-16       Impact factor: 4.599

3.  A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16.

Authors:  Elin Barnekow; Wen Liu; Hafdis T Helgadottir; Kyriaki Michailidou; Joe Dennis; Patrick Bryant; Jessada Thutkawkorapin; Camilla Wendt; Kamila Czene; Per Hall; Sara Margolin; Annika Lindblom
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.